US Patent 8153102 Process for manufacturing pharmaceutical composition comprises of

Patent 8153102 was granted and assigned to Cadila Pharmaceuticals on April, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Cadila Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8153102

Date of Patent

April 10, 2012

Patent Application Number

10565211

Date Filed

March 11, 2003

Patent Primary Examiner

‌

Rodney P Swartz

Patent abstract

The invention relates to process for the preparation of formulations comprising a microorganism Mycobacterium w for the management of bronchial Asthma (obstructive lung disease).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8153102 Process for manufacturing pharmaceutical composition comprises of

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API